You can teach an old drug new chemotherapy tricks. Researchers took a drug therapy proven for blood cancers but ineffective against solid tumors, packaged it with nanotechnology and got it to combat an aggressive type of breast cancer prevalent in young women, particularly young African-American women. The drug is arsenic and the cancer is triple negative breast cancer. It has a high risk of metastasizing and poor survival rates.